Indegene Share Price

    562
    -6.95 (-1.22%)
    INDGN • 26 Aug, 2025 | 03:29 PM
    Buy
    with MTF at2.86xleverage
    The current prices are delayed, login or Open Demat Account for live prices.

    Indegene Stock Performance

    1W Return-4.67
    1Y Return-0.29
    Today's Low558.55
    Prev. Close568.95
    Mkt Cap (Cr.)13,491.91
    1M Return1.11
    3Y Return0.00
    52-Week High736.3
    Open568.95
    PE Ratio69.49
    6M Return9.66
    Today's High568.95
    52-Week Low499
    Face Value2

    Indegene Company background

    Founded in: 1998
    Indegene Limited was incorporated as Indegene Lifesystems Private Limited at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad. Subsequently, name of the Company was changed to Indegene Private Limited and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. Thereafter, Company converted to a Public Company with change in name to Indegene Limited on November 17, 2022.The Company is a digitalfirst life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency. As a specialized company, it combine healthcare domain expertise, fitforpurpose technology, and an agile operating model to solve the most complex problems in the healthcare industry.Their Enterprise Commercial Solutions (ECS) involve assisting life sciences companies with their digital marketing operations. Omnichannel Activation solutions help life sciences companies leverage a digital first approach for optimizing the lastmile promotion of biopharmaceutical products and medical devices to HCPs across multiple channels. Under Enterprise Medical Solutions, the Company establish centers of excellence (CoEs) to consolidate large scale regulatory and medical operations for their clients.Apart from these, the Company offer Enterprise Clinical Solutions and consultancy services, which help drive efficiencies in the drug discovery and clinical trial operations of life sciences companies. It bring in their expertise in data management and analytics in helping biopharmaceutical companies seamlessly handle and analyze multiple sources of data during clinical trials and build a case for regulatory approvals.In 2016, the Company acquired Encima Group, Inc. in the United States, a company which provided marketing analytics and campaign execution solutions to several large life sciences companies. In 2019, it acquired a minority stake in DT Associates Research and Consulting Services Limited, a digital transformation and client experience consulting firm in UK, to expand their strategic consulting capabilities. In December 2020, it acquired a majority stake in DT Associates Limited.On 8 December, 2021 the Company has demerged its commercial software business pursuant to a Scheme of Arrangement for transfer of the Demerged Business to OT Services India Private Limited (Resulting Company), approved by the National Company Law Tribunal, Bengaluru Bench with Appointed Date, i.e., October 1, 2020, which became effective on December 30, 2021.The Company acquired Cult Health, a fullservice healthcare marketing agency for several life sciences brands, through its subsidiary, ILSL Holdings, Inc. on October 12, 2022.The Company launched Invisage, an AIenabled hybrid omnichannel sales and marketing platform in 2023. The Company made a public issue of 40,766,550 Equity Shares of face value of Rs 2 each by raising funds aggregating to Rs. 1842 Crore comprising a fresh issue of 16,833,818 Equity Shares aggregating to Rs. 760 Crore and 23,932,732 Equity Shares aggregating to Rs 1082 Crore through Offer for Sale in May, 2024.In 2024, the Company acquired a controlling stake in Trilogy Writing Consulting GmbH, a medical writing consultancy firm. It set up a new global delivery center in Hyderabad. In FY 2025, the Company launched a new center in Hyderabad to strengthen the business operations. In Europe, it launched a new entity in Spain and a new center in London. Indegenes Europebased clients became as a strategic hub for consulting and commercialization solutions and modernize their operations with an AIfirst approach. Further, the Company acquired MJL, a UKbased specialized healthcare advertising and communications agency. It launched Cortex, a fitforpurpose Generative AI platform for the life sciences industry.

    Indegene Financial Highlights


    Indegene reported a Q1 FY 2025-26 revenue of ₹760.8 crore, up 10.5% YoY, with net profit increased 20.8% to ₹116.4 crore. For the full year FY2025–2026, revenue reached ₹2946.5 crore and profit touched at ₹406.7 crore.

    As of 26 Aug, 2025, Indegene share price is ₹562. The stock opened at ₹569 and had closed at ₹569 the previous day. During today’s trading session, Indegene share price moved between ₹558.55 and ₹568.95, with an average price for the day of ₹563.75. Over the last 52 weeks, the stock has recorded a low of ₹499.00 and a high of ₹736.30. In terms of performance, Indegene share price has increased by 9.7% over the past six months and has increased by 0.94% over the last year.
    Read More
    View details of Market Depth

    Indegene Fundamental

    Market Cap (in crs)

    13,491.91

    Face Value

    2

    Turnover (in lacs)

    1,431.55

    Key Metrics

    Qtr Change %
    -7.7
    Dividend yield 1yr %
    Below industry Median
    0.4

    Indegene Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Indegene Quarterly Revenue
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    760.8 Cr
    755.6 Cr
    720.4 Cr
    686.8 Cr
    676.5 Cr
    Indegene Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    2946.5 Cr
    2665.9 Cr
    2364.1 Cr
    1690.5 Cr
    996.92 Cr
    Indegene Quarterly Net Profit/Loss
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    116.4 Cr
    117.6 Cr
    109.7 Cr
    91.7 Cr
    87.7 Cr
    Indegene Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    406.7 Cr
    336.7 Cr
    266.1 Cr
    162.82 Cr
    185.88 Cr

    Indegene Result Highlights

    • Indegene Ltd reported a 12.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 12.0%.

    • Its expenses for the quarter were up by 11.6% QoQ and 8.9% YoY.

    • The net profit increased 22.8% QoQ and increased 32.7% YoY.

    • The earnings per share (EPS) of Indegene Ltd stood at 4.8 during Q1 FY 2025-26.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Indegene Shareholding Pattern

    Foreign Institutions
    10%
    Mutual Funds
    3.4%
    Domestic Institutions
    7.2%
    Public
    82.8%
    Foreign Institutions
    5.2%
    Mutual Funds
    2.6%
    Domestic Institutions
    5%
    Public
    89.8%
    Foreign Institutions
    5%
    Mutual Funds
    1.6%
    Domestic Institutions
    4%
    Public
    91%
    Foreign Institutions
    4.8%
    Mutual Funds
    1.6%
    Domestic Institutions
    3.2%
    Public
    92%
    Foreign Institutions
    3.8%
    Mutual Funds
    2.3%
    Domestic Institutions
    3.8%
    Public
    92.4%

    Indegene Technical Analysis

    Moving Averages Analysis
    562
    Current Price
    Bullish Moving Averages
    0
    Bearish Moving Averages
    16
    5Day EMA
    569.90
    10Day EMA
    572.20
    12Day EMA
    572.20
    20Day EMA
    571.60
    26Day EMA
    571.40
    50Day EMA
    572.00
    100Day EMA
    575.20
    200Day EMA
    581.70
    5Day SMA
    571.10
    10Day SMA
    575.30
    20Day SMA
    570.70
    30Day SMA
    568.50
    50Day SMA
    570.00
    100Day SMA
    574.60
    150Day SMA
    574.60
    200Day SMA
    588.10
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    164559 Rs
    269219 Rs
    Week Rs
    159229 Rs
    288036 Rs
    Month Rs
    320586 Rs
    705186 Rs
    563.17
    Pivot
    Resistance
    First Resistance
    567.78
    Second Resistance
    573.57
    Third Resistance
    578.18
    Support
    First Support
    557.38
    Second support
    552.77
    Third Support
    546.98
    Relative Strength Index
    44.07
    Money Flow Index
    52.13
    MACD
    0.85
    MACD Signal
    1.64
    Average True Range
    13.76
    Average Directional Index
    11.60
    Rate of Change (21)
    1.11
    Rate of Change (125)
    0.95
    Name
    Holding Percent
    Sbi Innovative Opportunities Fund
    1.39
    Smallcap World Fund, Inc
    2.83
    Fidelity Funds - India Focus Fund
    1.75

    Indegene Latest News

    21 AUG 2025 | Thursday

    Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    19 AUG 2025 | Tuesday

    Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    13 AUG 2025 | Wednesday

    Indegene Ltd - 544172 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    View More

    Indegene Share Price FAQs

    Indegene share price is ₹562 in NSE and ₹561.5 in BSE as on 26/8/2025.

    Indegene share price in the past 1-year return was -0.29. The Indegene share hit a 1-year low of Rs. 499 and a 1-year high of Rs. 736.3.

    The market cap of Indegene is Rs. 13491.91 Cr. as of 26/8/2025.

    The PE ratios of Indegene is 69.48 as of 26/8/2025.

    The PB ratios of Indegene is 7.14 as of 26/8/2025

    The Mutual Fund Shareholding in Indegene was 3.37% at the end of 26/8/2025.

    You can easily buy Indegene shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Indegene share price is ₹736.3 and ₹499 as of 26/8/2025.

    The earnings per share (EPS) of Indegene stood at 4.8 during Q1 FY 2025-26.

    Please be aware that Indegene stock prices are subject to continuous fluctuations due to various factors.

    Open Demat Account
    +91 -

    Popular Stocks
    56.97
    -0.46 (-0.80%)
    121.20
    -3.16 (-2.54%)
    681.65
    -5.15 (-0.75%)
    2,272.00
    -30.90 (-1.34%)
    144.17
    -3.53 (-2.39%)
    312.70
    -8.95 (-2.78%)
    155.03
    -4.60 (-2.88%)
    317.90
    -1.35 (-0.42%)
    365.85
    -6.20 (-1.67%)
    377.75
    -5.50 (-1.44%)
    Top Gainers
    6,151.00
    +160.50 (+2.68%)
    2,692.60
    +61.00 (+2.32%)
    14,714.00
    +262.00 (+1.81%)
    403.35
    +4.00 (+1.00%)
    1,162.20
    +9.20 (+0.80%)
    Top Losers
    594.70
    -26.15 (-4.21%)
    1,600.30
    -56.40 (-3.40%)
    155.03
    -4.60 (-2.88%)
    876.25
    -24.55 (-2.73%)
    5,295.00
    -128.00 (-2.36%)
    Open Demat Account
    +91 -